New York State Common Retirement Fund Logic Bio Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.85 - $5.09 $527 - $697	-137 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$4.03 - $7.57 $22,821 - $42,868	-5,663 Reduced 97.64%	137 $1,000
Q1 2019 May 08, 2019	BUY	$7.93 - $10.41 $45,994 - $60,378	5,800 New	5,800 $57,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.